The stereotactic radiosurgery-brain prognostic index (SRS-BPI): A novel prognostic index for SRS-eligible lung cancer patients with brain metastases

The SRS-BPI emerges as an internally validated, advanced prognostic tool, providing enhanced decision-making support for lung cancer patients with BM who are candidates for SRS. Although internally validated, external validation is essential and is currently in progress.